Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cardiff Oncology, Inc.

2.64
+0.270011.39%
Post-market: 2.640.00000.00%19:44 EDT
Volume:5.88M
Turnover:15.25M
Market Cap:175.63M
PE:-3.03
High:2.79
Open:2.46
Low:2.39
Close:2.37
Loading ...

Cardiff Oncology (CRDF) Q2 Loss Down 19%

Motley Fool
·
31 Jul

BRIEF-Cardiff Oncology Announces Positive Data From Ongoing Randomized Phase 2 First-Line Ras-Mutated Mcrc Clinical Trial (Crdf-004)

Reuters
·
30 Jul

Cardiff Oncology Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $121.00K Beat $92.86K Estimate

Benzinga
·
30 Jul

Cardiff Oncology Inc - Trial Shows 49% Orr in 30Mg Onvansertib Dose Arm

THOMSON REUTERS
·
30 Jul

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

GlobeNewswire
·
30 Jul

Cardiff Oncology Inc - Has $71 Mln Cash as of June 30, Runway Into Q1 2027

THOMSON REUTERS
·
30 Jul

Cardiff Oncology Inc - Completes Enrollment in Phase 2 Crdf-004 Trial

THOMSON REUTERS
·
30 Jul

Largest borrow rate increases among liquid names

TIPRANKS
·
14 Jul

Cardiff Oncology (CRDF) Initiated with a Buy at Ladenburg Thalmann & Co.

TIPRANKS
·
11 Jul

Cardiff Oncology Inc. Files Initial Statement of Beneficial Ownership for Roger Sidhu, Chief Medical Officer

Reuters
·
09 Jul

Cardiff Oncology Initiated at Buy by Ladenburg Thalmann

Dow Jones
·
09 Jul

ADVISORY-Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn

Reuters
·
08 Jul

Cardiff Oncology Inc. Concluded Annual Stockholders Meeting

Reuters
·
27 Jun

Cardiff Oncology Initiated at Hold by Jefferies

Dow Jones
·
24 Jun

Cardiff Oncology (CRDF) Receives a New Rating from Jefferies

TIPRANKS
·
24 Jun

Craig-Hallum Sticks to Their Buy Rating for Cardiff Oncology (CRDF)

TIPRANKS
·
18 Jun

Cardiff Oncology Inc. Appoints Dr. Roger Sidhu as Chief Medical Officer Amid Leadership Transition

Reuters
·
18 Jun

Cardiff Oncology's Phase 1b Trial for Breast Cancer Treatment Shows 40% Objective Response Rate

MT Newswires Live
·
03 Jun

Cardiff Oncology ‘highly encouraged’ by onvansertib data presented at ASCO

TIPRANKS
·
03 Jun

Piper Sandler Remains a Buy on Cardiff Oncology (CRDF)

TIPRANKS
·
09 May